Bioventus (BVS) - 2025 Q4 - Earnings Call Presentation

Agenda and Speakers Rob Claypoole President and Chief Executive Officer Update on Business and 2026 Priorities Fourth Quarter 2025 Financial Results March 5, 2026 Mark Singleton Senior Vice-President and Chief Financial Officer Q4 2025 Results 2026 Financial Guidance 2 Forward Looking Statements and Use of Estimates Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Ex ...